The present, updated document describes the fourth iteration of recommendations for the
hepatic use of contrast enhanced ultrasound (CEUS), first initiated in 2004 by the European …

Contrast-enhanced ultrasound (CEUS) has become an established modality in various
clinical indications for liver diseases. SonoVue®, a pure blood pure agent, and Sonazoid® …

Objectives Percutaneous liver biopsy (LB) has been considered the reference standard in
distinguishing the degree of liver disease, but there has been no definitive systematic review …

The first edition of the guidelines for the use of ultrasound contrast agents was published in
2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected …

The aim of this article is to provide an inventory of the use of contrast‐enhanced ultrasound
(CEUS) in relation to percutaneous interventional procedures. The article is structured into a …

In this study, a total of 58 patients with single subpleural pulmonary lesions (males: 36,
females: 22, mean age: 63±16.2 years) who underwent contrast-enhanced ultrasonography …

The use of contrast-enhanced ultrasonography (CEUS) has recently become synonymous
with high-standard ultrasonography (US). From expanding the reach of US diagnostics to …

摘要背景与目的: 超声常用于引导微波消融(MWA) 治疗肝细胞癌(HCC). 部分MWA 可经皮完成,
对于特殊部位HCC, 则常选择通过腹腔镜完成. 腹腔镜下MWA 亦存在局限, 对于小肝癌 …

We aimed to compare contrast-enhanced–guided liver biopsy (CEUSLB) and ultrasound-
guided liver biopsy (USLB) in the diagnosis of focal liver lesions (FLLs) developed on a …

Incidental liver masses are commonly identified on imaging performed for other indications.
Since the prevalence of benign focal liver lesions in adults is high, even in patients with …